Zobrazeno 1 - 10
of 2 182
pro vyhledávání: '"J. Herzog"'
Autor:
M. Sicorello, J. Herzog, T.D. Wager, G. Ende, M. Müller-Engelmann, S.C. Herpertz, M. Bohus, C. Schmahl, C. Paret, I. Niedtfeld
Publikováno v:
Neuroimage: Reports, Vol 1, Iss 2, Pp 100019- (2021)
Pathophysiological models are urgently needed for personalized treatments of mental disorders. However, most potential neural markers for psychopathology are limited by low interpretability, prohibiting reverse inference from brain measures to clinic
Externí odkaz:
https://doaj.org/article/58be6472c63f49b58d219a24c5b7ebfe
Autor:
J. Herzog, F. von Klot-Heydenfeldt, S. Jabar, A. Ranft, C. Rossig, U. Dirksen, J. Van den Brande, M. D’Incalci, I. von Luettichau, P. J. Grohar, W. E. Berdel, St. Burdach
Publikováno v:
Sarcoma, Vol 2016 (2016)
Background. Preclinical data indicate that trabectedin followed by irinotecan has strong synergistic effects on Ewing sarcoma. This is presumably due to hypersensitization of the tumor cells to the camptothecin as an effect of trabectedin in addition
Externí odkaz:
https://doaj.org/article/42a82ead95244ea38f1c18b197b6a1fe
Autor:
Bryan K. Mignone, Leon Clarke, James A. Edmonds, Angelo Gurgel, Howard J. Herzog, Jeremiah X. Johnson, Dharik S. Mallapragada, Haewon McJeon, Jennifer Morris, Patrick R. O’Rourke, Sergey Paltsev, Steven K. Rose, Daniel C. Steinberg, Aranya Venkatesh
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Energy transition scenarios are characterized by increasing electrification and improving efficiency of energy end uses, rapid decarbonization of the electric power sector, and deployment of carbon dioxide removal (CDR) technologies to offse
Externí odkaz:
https://doaj.org/article/ccd60468667640389a2a716a4cf778a7
Autor:
Binu M. Suresh, Nitsa J. Herzog
Publikováno v:
Digital, Vol 4, Iss 2, Pp 410-424 (2024)
Efficient triaging and referral assessments are critical in ensuring prompt medical intervention in the community healthcare (CHC) system. However, the existing triaging systems in many community health services are an intensive, time-consuming proce
Externí odkaz:
https://doaj.org/article/50cb79f9d86947d28054b368de2908df
Autor:
Philippe J. Herzog, Rose D. L. Herzog-Zibi, Martina Mattmann, Charlotte Möri, Blandine Mooser, Jennifer Inauen, Carole E. Aubert
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Low mobility during an acute care medical hospitalization is frequent and associated with adverse outcomes, particularly among older patients. Better understanding barriers and facilitators to improve mobility during hospitalizati
Externí odkaz:
https://doaj.org/article/c4b16e10eb1746a68dec98ea74a739db
Autor:
Mary C. Bedard, Tafadzwa Chihanga, Adrean Carlile, Robert Jackson, Marion G. Brusadelli, Denis Lee, Andrew VonHandorf, Mark Rochman, Phillip J. Dexheimer, Jeffrey Chalmers, Gerard Nuovo, Maria Lehn, David E. J. Williams, Aditi Kulkarni, Molly Carey, Amanda Jackson, Caroline Billingsley, Alice Tang, Chad Zender, Yash Patil, Trisha M. Wise-Draper, Thomas J. Herzog, Robert L. Ferris, Ady Kendler, Bruce J. Aronow, Matthew Kofron, Marc E. Rothenberg, Matthew T. Weirauch, Koenraad Van Doorslaer, Kathryn A. Wikenheiser-Brokamp, Paul F. Lambert, Mike Adam, S. Steven Potter, Susanne I. Wells
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
The role of keratinocyte subpopulations in the different phases of the viral cycle during HPV16 infection remains to be characterised. Here, single cell RNA sequencing of HPV16 infected and uninfected organoids identifies 12 distinct keratinocyte pop
Externí odkaz:
https://doaj.org/article/944133d8df914bc3ab573aab9d9f4d14
Autor:
Ramez N. Eskander, Kathleen N. Moore, Bradley J. Monk, Thomas J. Herzog, Christina M. Annunziata, David M. O’Malley, Robert L. Coleman
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The definition of “platinum-resistant ovarian cancer” has evolved; it now also reflects cancers for which platinum treatment is no longer an option. Standard of care for platinum-resistant ovarian cancer is single-agent, non-platinum chemotherapy
Externí odkaz:
https://doaj.org/article/358e10443d3f428898b57cc9d3f7a136
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101224- (2023)
Gestational trophoblastic neoplasia (GTN) consists of rare malignancies of the placenta with a known propensity to metastasize to the lungs. GTN is treated with chemotherapeutic agents known to cause lung injury, further placing patients at risk for
Externí odkaz:
https://doaj.org/article/21cc461186b044d387c8e30fe116b80e
Autor:
Erica V. Carballo, Sharon Wu, Kartik Angara, Courtney A. Penn, Thomas J. Herzog, Premal Thaker, Kristen Starbuck
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp S1- (2023)
Objectives: Our aim is to examine the immune microenvironment of endometrial cancer (EMCA) patients treated with pembrolizumab plus lenvatinib (P+L) that could contribute to increased time on treatment. This may help inform patient selection and iden
Externí odkaz:
https://doaj.org/article/4236309929ce446ebe4c6b7fdb0d6cca
Autor:
Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-9 (2022)
Abstract Background Broadened use of predictive molecular and phenotypic profiling amongst oncologists has facilitated optimal integration of targeted- and immuno-therapeutics into clinical care. However, the use of predictive immunomarkers in ovaria
Externí odkaz:
https://doaj.org/article/021ed7667e0a4a57b9255b4a5c98cf92